Patents by Inventor Dibyendu Dana

Dibyendu Dana has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • GAMMA-HYDROXYBUTYRATE DELIVERING COMPOUNDS AND PROCESSES FOR MAKING AND USING THEM
    Publication number: 20230382851
    Abstract: Disclosed are one or more compounds comprising chemically modified gamma-hydroxybutyrate (GHB), 2-hydroxytetrahydrofuran, and/or 1,4-butanediol, and salts of such compounds (GHB delivering compounds and salts thereof). Also disclosed are compositions comprising at least one GHB delivering compound, or a salt thereof, methods of making such compounds, and methods of using such GHB delivering compounds and compositions. Methods of treatment using the compounds are also disclosed.
    Type: Application
    Filed: April 19, 2023
    Publication date: November 30, 2023
    Inventors: Sanjib BERA, Dibyendu DANA, Sven GUENTHER, Adam SMITH, Travis MICKLE
  • GAMMA-HYDROXYBUTYRATE DELIVERING COMPOUNDS AND PROCESSES FOR MAKING AND USING THEM
    Publication number: 20230382881
    Abstract: Disclosed are one or more compounds comprising chemically modified gamma-hydroxybutyrate (GHB), 2-hydroxytetrahydrofuran, and/or 1,4-butanediol, and salts of such compounds (GHB delivering compounds and salts thereof). Also disclosed are compositions comprising at least one GHB delivering compound, or a salt thereof, methods of making such compounds, and methods of using such GHB delivering compounds and compositions. Methods of treatment using the compounds are also disclosed.
    Type: Application
    Filed: April 19, 2023
    Publication date: November 30, 2023
    Inventors: Sanjib BERA, Dibyendu DANA, Sven GUENTHER, Adam SMITH, Travis MICKLE
  • GAMMA-HYDROXYBUTYRATE DELIVERING COMPOUNDS AND PROCESSES FOR MAKING AND USING THEM
    Publication number: 20230338543
    Abstract: Disclosed are compounds comprising chemically modified gamma-hydroxybutyrate (GHB), 2-hydroxytetrahydrofuran, and/or 1,4-butanediol, and salts of such compounds (GHB delivering compounds and salts thereof). Also disclosed are compositions comprising at least one GHB delivering compound, or a salt thereof, methods of making such compounds, and methods of using such GHB delivering compounds and compositions.
    Type: Application
    Filed: April 19, 2023
    Publication date: October 26, 2023
    Inventors: Sanjib BERA, Dibyendu DANA, Sven GUENTHER, Adam SMITH, Travis MICKLE
  • Vinylheterocycles as Rho-associated coiled-coil kinase (ROCK) inhibitors
    Patent number: 11542256
    Abstract: The present invention provides compounds having formula (I): and pharmaceutically acceptable salts thereof, wherein Cy1, Cy2, Cy3, R, R1, R2, R3, A1 and A2 are as described generally and in classes and subclasses herein, and additionally provides pharmaceutical compositions thereof, and methods for the use thereof for the treatment of any of a number of conditions or diseases in which inhibiting ROCK1, ROCK2, or ROCK1/2 has a therapeutically useful role.
    Type: Grant
    Filed: August 31, 2018
    Date of Patent: January 3, 2023
    Assignee: Angion Biomedica Corp.
    Inventors: An-Hu Li, Dibyendu Dana, Dong Sung Lim, Satishkumar Gadhiya, Dawoon Jung, Prakash Narayan, Quaisar Ali, Swarnalatha Paka, Itzhak D. Goldberg
  • VINYLHETEROCYCLES AS RHO-ASSOCIATED COILED-COIL KINASE (ROCK) INHIBITORS
    Publication number: 20200231576
    Abstract: The present invention provides compounds having formula (I): and pharmaceutically acceptable salts thereof, wherein Cy1, Cy2, Cy3, R, R1, R2, R3, A1 and A2 are as described generally and in classes and subclasses herein, and additionally provides pharmaceutical compositions thereof, and methods for the use thereof for the treatment of any of a number of conditions or diseases in which inhibiting ROCK1, ROCK2, or ROCK1/2 has a therapeutically useful role.
    Type: Application
    Filed: August 31, 2018
    Publication date: July 23, 2020
    Inventors: An-Hu Li, Dibyendu Dana, Dong Sung Lim, Satishkumar Gadhiya, Dawoon Jung, Prakash Narayan, Quaisar Ali, Latha Paka, Itzhak D. Goldberg
  • Cathepsin L inhibitors and probes comprising vinyl sulfonate moiety and methods of using same
    Patent number: 9481876
    Abstract: Human cathepsin L inhibitors and probes containing a vinyl sulfonate ester moiety are described. The inhibitors are highly potent (low nM affinity), selective, and cell permeable, and can inhibit ultra-low concentration of active cathepsin L. The developed probes are highly sensitive and can detect an ultra-low amount of probe-labeled active cathespin L.
    Type: Grant
    Filed: May 26, 2015
    Date of Patent: November 1, 2016
    Assignee: Research Foundation of the City University of New York
    Inventors: Sanjai Kumar, Dibyendu Dana
  • CATHEPSIN L INHIBITORS AND PROBES COMPRISING VINYL SULFONATE MOIETY AND METHODS OF USING SAME
    Publication number: 20150337286
    Abstract: Human cathepsin L inhibitors and probes containing a vinyl sulfonate ester moiety are described. The inhibitors are highly potent (low nM affinity), selective, and cell permeable, and can inhibit ultra-low concentration of active cathepsin L. The developed probes are highly sensitive and can detect an ultra-low amount of probe-labeled active cathespin L.
    Type: Application
    Filed: May 26, 2015
    Publication date: November 26, 2015
    Inventors: Sanjai Kumar, Dibyendu Dana